CLINILABS Drug Development Corp is a clinical research site located in Eatontown, New Jersey, United States 07724.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
CLINILABS Drug Development Corp has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Friedreich Ataxia, Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency.
Sponsors: Larimar Therapeutics, Inc., Inozyme Pharma.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Eatontown
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CLINILABS Drug Development Corp has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CLINILABS Drug Development Corp has 2 clinical trials on record, with 2 currently active. Their work covers Friedreich Ataxia, Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency.
CLINILABS Drug Development Corp has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.